Reata Pharmaceuticals Inc (RETA)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
Duquesne Capital

Stanley Druckenmiller

637,344 $90,203 -16% 2.58%
2. 465,000 $65,811 +17% 2.21%
3.
Deerfield Management

James E. Flynn

300,000 $42,459 -29% 0.75%
4.
Baker Bros. Advisors

Julian Baker And Felix Baker

223,976 $31,699 0.13%
5.
Ikarian CapitalPUT

Neil Shahrestani

174,900 $24,755 +67% 2%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$100.19 1,000 Officer 3,000 2020-08-14 Filing
$100.22 2,000 Officer 2,000 2020-08-14 Filing
$183.00 40,218 3,063,567 2019-11-18 Filing
$183.00 40,218 3,063,567 2019-11-18 Filing
$183.00 5,464 5,464 2019-11-18 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$145.92 500 Officer 17,000 2021-06-15 Filing
$145.11 1,217 Officer 17,500 2021-06-15 Filing
$143.98 2,483 Officer 18,717 2021-06-15 Filing
$142.83 8,867 Officer 21,200 2021-06-15 Filing
$142.08 12,518 Officer 30,067 2021-06-15 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 31,954 $4,522,451 0%
2. 5,970 $844,934 0%
3. 4,326,468 $612,325 0.1%
4. 2,896,901 $409,998 67.78%
5. 2,809,716 $397,659 0.11%
News See All